These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
3. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization. Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies. Gong W; Parkkila S; Wu X; Aspatwar A Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216 [TBL] [Abstract][Full Text] [Related]
5. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern. Akkız H Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924 [TBL] [Abstract][Full Text] [Related]
6. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor. Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM Front Immunol; 2022; 13():871874. PubMed ID: 35898497 [TBL] [Abstract][Full Text] [Related]
7. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2's Variants of Concern: A Brief Characterization. Scovino AM; Dahab EC; Vieira GF; Freire-de-Lima L; Freire-de-Lima CG; Morrot A Front Immunol; 2022; 13():834098. PubMed ID: 35958548 [TBL] [Abstract][Full Text] [Related]
10. Research progress in spike mutations of SARS-CoV-2 variants and vaccine development. He X; He C; Hong W; Yang J; Wei X Med Res Rev; 2023 Jul; 43(4):932-971. PubMed ID: 36929527 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. Yang W; Shaman J medRxiv; 2021 Nov; ():. PubMed ID: 34845460 [TBL] [Abstract][Full Text] [Related]
12. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
13. Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis. Thye AY; Law JW; Pusparajah P; Letchumanan V; Chan KG; Lee LH Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680420 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants. Yogesh R; Srivastava N; Abbas Bukhari SN Curr Pharm Des; 2022; 28(35):2901-2913. PubMed ID: 35786330 [TBL] [Abstract][Full Text] [Related]
15. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19. Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity. Liu H; Wei P; Kappler JW; Marrack P; Zhang G Front Immunol; 2022; 13():825256. PubMed ID: 35154144 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape. Yang L; Li J; Guo S; Hou C; Liao C; Shi L; Ma X; Jiang S; Zheng B; Fang Y; Ye L; He X Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829998 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig. Li Y; Wang H; Tang X; Fang S; Ma D; Du C; Wang Y; Pan H; Yao W; Zhang R; Zou X; Zheng J; Xu L; Farzan M; Zhong G J Virol; 2020 Oct; 94(22):. PubMed ID: 32847856 [TBL] [Abstract][Full Text] [Related]
19. Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants. da Silva SJR; de Lima SC; da Silva RC; Kohl A; Pena L Front Med (Lausanne); 2021; 8():836826. PubMed ID: 35174189 [TBL] [Abstract][Full Text] [Related]
20. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection. Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]